Stay updated with breaking news from Trevena Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trevena (NASDAQ: TRVN) recently received a number of ratings updates from brokerages and research firms: 6/1/2024 – Trevena is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 5/24/2024 – Trevena is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 5/16/2024 – Trevena is […]
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their price objective on Trevena from $9.00 to $5.00 and set a buy rating on the stock in a research note on Thursday, […]
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report issued on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright cut their target price on shares of Trevena from $9.00 to $5.00 and set a buy rating for the company in a research note […]
Trevena (NASDAQ:TRVN – Free Report) had its price objective cut by HC Wainwright from $9.00 to $5.00 in a report issued on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Separately, StockNews.com assumed coverage on Trevena in a research note on Thursday. They set a sell rating for […]
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report published on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $9.00 target price on shares of Trevena in a report on Tuesday, April 2nd. Get Our Latest […]